These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25192381)

  • 21. Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
    Boyko EJ; Gerstein HC; Mohan V; Yusuf S; Sheridan P; Anand S; Shaw JE;
    Diabet Med; 2010 Nov; 27(11):1226-32. PubMed ID: 20950379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis.
    Li Y; Tong Y; Zhang Y; Huang L; Wu T; Tong N
    Int J Clin Pract; 2014 Nov; 68(11):1318-32. PubMed ID: 24853116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.
    Rosenstock J; Seman LJ; Jelaska A; Hantel S; Pinnetti S; Hach T; Woerle HJ
    Diabetes Obes Metab; 2013 Dec; 15(12):1154-60. PubMed ID: 23906374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin: an update.
    Kirpichnikov D; McFarlane SI; Sowers JR
    Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase-4 inhibition.
    Ahrén B
    J Diabetes Investig; 2021 Jul; 12(7):1128-1135. PubMed ID: 33949781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview.
    Davidson JA; Sloan L
    Adv Ther; 2017 Jan; 34(1):41-59. PubMed ID: 27854055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
    González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
    J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin for pregnancy and beyond: the pros and cons.
    Newman C; Dunne FP
    Diabet Med; 2022 Mar; 39(3):e14700. PubMed ID: 34569082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When metformin fails in type 2 diabetes mellitus.
    Esposito K; Bellastella G; Giugliano D
    Arch Intern Med; 2011 Feb; 171(4):365-6. PubMed ID: 21357815
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of linagliptin in Asian patients with type 2 diabetes mellitus inadequately controlled by metformin: A multinational 24-week, randomized clinical trial.
    Wang W; Yang J; Yang G; Gong Y; Patel S; Zhang C; Izumoto T; Ning G
    J Diabetes; 2016 Mar; 8(2):229-37. PubMed ID: 25753488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
    Wilson JA; Scott MM; Gray RS
    Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
    Kendall DM; Riddle MC; Rosenstock J; Zhuang D; Kim DD; Fineman MS; Baron AD
    Diabetes Care; 2005 May; 28(5):1083-91. PubMed ID: 15855571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Woo V;
    Diabetes Care; 2009 Mar; 32(3):e34; author reply e37-8. PubMed ID: 19246585
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.
    DeFronzo RA; Ratner RE; Han J; Kim DD; Fineman MS; Baron AD
    Diabetes Care; 2005 May; 28(5):1092-100. PubMed ID: 15855572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full title: High glucose protects mesenchymal stem cells from metformin-induced apoptosis through the AMPK-mediated mTOR pathway.
    He X; Yang Y; Yao MW; Ren TT; Guo W; Li L; Xu X
    Sci Rep; 2019 Nov; 9(1):17764. PubMed ID: 31780804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
    Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R;
    Rev Clin Esp; 2011 Mar; 211(3):147-55. PubMed ID: 21376312
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
    Menéndez Torre E; Lafita Tejedor FJ; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García Á; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R;
    Endocrinol Nutr; 2011 Mar; 58(3):112-20. PubMed ID: 21354873
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of treating hypertension, hyperglycemia, and hyperlipidemia in African Americans and the general population with type 2 diabetes.
    Tasosa J; Schuster R; McAlearney JS
    J Health Care Poor Underserved; 2010 Feb; 21(1):161-76. PubMed ID: 20173262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia.
    Haak T
    Adv Ther; 2012 Dec; 29(12):1005-15. PubMed ID: 23212658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.